Add Arakoda to Your List of Malaria Prophylaxis Options

August 2019

Arakoda (air-uh-KOH-duh, tafenoquine) will be the first new med approved in nearly 20 years to prevent malaria in adults.

It's given once daily for 3 days before travel to any endemic area...once WEEKLY during travel...and then once after returning.

Expect many patients to prefer this simpler dosing.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Photosensitivity Identify and Manage Med-Induced Photosensitivity
Insulin Help Patients With Skyrocketing Insulin Costs
Opioids Don't Think of Tramadol as a "Safer" Opioid
Lupus Be Familiar With Nuances for Managing Lupus
Pregnancy Weigh OTC Options for Treating GI Issues in Pregnancy
HIV & AIDS Know How to Manage Dyslipidemia in Patients Living With HIV
Diabetes Consider Cardiovascular Benefits When Choosing a GLP-1 Agonist
Antimalarials Add Arakoda to Your List of Malaria Prophylaxis Options
Liver Disease Maximize Safety When Using Anticoagulants in Patients With Cirrhosis
Patient Safety Tell Patients to Avoid Unsafe Stem Cells